Contact – +1-276-477-5910
 Email – [email protected]

Home >> Reports

 Reports


Asia Pacific Pharmaceutical Packaging Market 2020-2027 by Packaging Category (Primary, Secondary, Tertiary), Product, Raw Material, Pharmaceutical Dosage Form, Drug Delivery Mode, End User, and Country: Trend Outlook and Growth Opportunity

Asia Pacific pharmaceutical packaging market will grow by 8.2% annually with a total addressable market cap of $253.76 billion over 2021-2027 owing to the increase in healthcare coverage, growing aging population, an increase in non-communicable disease, new drug development and government initiatives to promote innovations in the pharmaceutical industry. Highlighted with 33 tables and 65 figures, this 117-page report “Asia Pacific Pharmaceutical Packaging Market 2020-2027 by Packaging Category...

 44407 |  Healthcare and Social Assistance


Europe Pharmaceutical Packaging Market 2020-2027 by Packaging Category (Primary, Secondary, Tertiary), Product, Raw Material, Pharmaceutical Dosage Form, Drug Delivery Mode, End User, and Country: Trend Outlook and Growth Opportunity

Europe pharmaceutical packaging market accounted for $29.19 billion in 2020 and will grow by 5.8% annually over 2020-2027 owing to the increase in healthcare coverage, growing aging population, an increase in non-communicable disease, new drug development and government initiatives to promote innovations in the pharmaceutical industry. Highlighted with 36 tables and 66 figures, this 118-page report “Europe Pharmaceutical Packaging Market 2020-2027 by Packaging Category (Primary, Secondary, Tert...

 44407 |  Healthcare and Social Assistance


North America Pharmaceutical Packaging Market 2020-2027 by Packaging Category (Primary, Secondary, Tertiary), Product, Raw Material, Pharmaceutical Dosage Form, Drug Delivery Mode, End User, and Country: Trend Outlook and Growth Opportunity

North America pharmaceutical packaging market is expected to grow by 6.4% annually in the forecast period and reach $41.88 billion by 2027 owing to the increase in healthcare coverage, growing aging population, an increase in non-communicable disease, new drug development and government initiatives to promote innovations in the pharmaceutical industry. Highlighted with 26 tables and 62 figures, this 111-page report “North America Pharmaceutical Packaging Market 2020-2027 by Packaging Category (...

 44407 |  Healthcare and Social Assistance


Global Pharmaceutical Packaging Market 2020-2027 by Packaging Category (Primary, Secondary, Tertiary), Product, Raw Material, Pharmaceutical Dosage Form, Drug Delivery Mode, End User, and Region: Trend Outlook and Growth Opportunity

Global pharmaceutical packaging market will reach $151.08 billion by 2027, growing by 6.8% annually over 2020-2027 owing to the increase in healthcare coverage, growing aging population, an increase in non-communicable disease, new drug development and government initiatives to promote innovations in the pharmaceutical industry. Highlighted with 85 tables and 95 figures, this 171-page report “Global Pharmaceutical Packaging Market 2020-2027 by Packaging Category (Primary, Secondary, Tertiary), ...

 44407 |  Healthcare and Social Assistance


Asia Pacific Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity

Asia Pacific organ-on-chip market will grow by 35.1% annually with a total addressable market cap of $399.4 million over 2021-2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, the significant increase in research funding and venture capital investments. Highlighted with 30 tables and 50 figures, this 105-page report “Asia Pacific Organ-on-Chip Market 202...

 44407 |  Healthcare and Social Assistance


Europe Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity

Europe organ-on-chip market accounted for $6.9 million in 2020 and will grow by 32.2% annually over 2020-2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, the significant increase in research funding and venture capital investments. Highlighted with 33 tables and 51 figures, this 106-page report “Europe Organ-on-Chip Market 2020-2030 by Offering (Chips, ...

 44407 |  Healthcare and Social Assistance


North America Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity

North America organ-on-chip market is expected to grow by 33.7% annually in the forecast period and reach $178.6 million by 2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, the significant increase in research funding and venture capital investments. Highlighted with 23 tables and 47 figures, this 99-page report “North America Organ-on-Chip Market 2020-...

 44407 |  Healthcare and Social Assistance


Global Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Region: Trend Forecast and Growth Opportunity

Global organ-on-chip market will reach $420.6 million by 2030, growing by 33.5% annually over 2020-2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, the significant increase in research funding and venture capital investments. Highlighted with 82 tables and 83 figures, this 160-page report “Global Organ-on-Chip Market 2020-2030 by Offering (Chips, Servic...

 44407 |  Healthcare and Social Assistance


Asia Pacific Multiple Sclerosis Drugs Market 2020-2027 by Drug Type (Immunomodulators, Immunosuppressants), Drug Class, Drug Category (Large-molecule, Small-molecule), Route of Administration (Oral, Parenteral), MS Type (RRMS, PPMS, SPMS, PRMS), Distribution Channel, and Country: Trend Outlook and Growth Opportunity

Asia Pacific multiple sclerosis drugs market will grow by 6.5% annually with a total addressable market cap of $33.56 billion over 2120-2027 owing to the growing prevalence of multiple sclerosis (MS), the rise in funding for multiple sclerosis research, and increasing approvals of novel MS drugs. Highlighted with 35 tables and 54 figures, this 110-page report “Asia Pacific Multiple Sclerosis Drugs Market 2020-2027 by Drug Type (Immunomodulators, Immunosuppressants), Drug Class, Drug Category (L...

 44407 |  Healthcare and Social Assistance


Europe Multiple Sclerosis Drugs Market 2020-2027 by Drug Type (Immunomodulators, Immunosuppressants), Drug Class, Drug Category (Large-molecule, Small-molecule), Route of Administration (Oral, Parenteral), MS Type (RRMS, PPMS, SPMS, PRMS), Distribution Channel, and Country: Trend Outlook and Growth Opportunity

Europe multiple sclerosis drugs market accounted for $5,668.0 million in 2020 and will grow by 4.2% annually over 2020-2027 owing to the growing prevalence of multiple sclerosis (MS), the rise in funding for multiple sclerosis research, and increasing approvals of novel MS drugs. Highlighted with 38 tables and 55 figures, this 111-page report “Europe Multiple Sclerosis Drugs Market 2020-2027 by Drug Type (Immunomodulators, Immunosuppressants), Drug Class, Drug Category (Large-molecule, Small-mo...

 44407 |  Healthcare and Social Assistance


x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT